NEW YORK, Sept. 11, 2014 (GLOBE NEWSWIRE) -- The Rosen Law Firm announces today that a class action lawsuit has been filed on behalf of all purchasers of the securities of InVivo Therapeutics Holdings Corp. (OTC:NVIV) between April 5, 2013 and August 26, 2013, seeking remedies under the federal securities laws.
To join the InVivo Therapeutics class action, go to the website at http://rosenlegal.com/cases-355.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or kchan@rosenlegal.com for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, the Company misstated and/or failed to disclose the true amount of time required to submit data to the FDA in the Company's biopolymer scaffolding product. On August 27, 2013, the Company admitted that its previously announced target date for completing the study and providing its data to the FDA would not be met due to condition established by the FDA. The lawsuit claims that when this adverse news entered the market the price of the Company' stock dropped, damaging investors.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 6, 2014. If you wish to join the litigation go to http://rosenlegal.com/cases-355.html or to discuss your rights or interests regarding this class action, please contact, Phillip Kim, Esq. or Kevin Chan, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or kchan@rosenlegal.com.
The Rosen Law Firm focuses on prosecuting securities class action litigation and actions involving financial fraud. The Rosen Law Firm represents investors throughout the globe.